Earlier this year, Ro launched the GLP-1 Supply Tracker, an open-access tool set up to help patients and providers keep track of which GLP-1 medications are in stock and which are in shortage
I didn't have to worry about it, and not have to feel like someone was looking at me sideways." Appearing on the 3rd Hour of TODAY, Williams said that she wanted to come forward because "a lot of people are actually on GLP-1s but don't really want to talk about it, don't want to say it." "That's why I feel like my story is so important because I'm so active," she adds
Visser M, Goodpaster BH, Kritchevsky SB, Newman AB, Nevitt M, Rubin SM, Simonsick EM, Harris TB
In response, some individuals explore microdosing as a way to improve tolerability, manage side effects, and create a more sustainable experience with GLP-1 therapy
These platforms typically require patients to complete detailed medical questionnaires and may include video consultations with prescribers
Final rule expected late 2026